These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15088913)

  • 61. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin.
    Gerber GS; Kim JH; Contreras BA; Steinberg GD; Rukstalis DB
    Urology; 1996 Jun; 47(6):840-4. PubMed ID: 8677574
    [TBL] [Abstract][Full Text] [Related]  

  • 62. EFFICACY OF SILODOSIN (UROREC®) IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: THE MAXIMUM DECREASE OF BLADDER OUTLET OBSTRUCTION INDEX.
    Khamzin A; Frolov R
    Georgian Med News; 2018 Mar; (276):18-23. PubMed ID: 29697376
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical and pressure-flow changes after long-term treatment with alfuzosin SR.
    De Nunzio C; Franco G; Iori F; Leonardo C; Minardi V; Laurenti C
    Urol Int; 2003; 71(1):31-6. PubMed ID: 12845257
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of passive urethral resistance relation and urethral resistance factor in analysis of bladder outlet obstruction in patients with benign prostatic enlargement.
    Rosier PF; de la Rosette JJ; de Wildt MJ; Debruyne FM; Wijkstra H
    Neurourol Urodyn; 1996; 15(1):1-10; discussion 10-5. PubMed ID: 8696351
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Residual fraction in the evaluation of bladder outlet obstruction resulting from benign prostatic hyperplasia].
    Cheng W; Gao JP; Zhang ZY; Ge JP; Xue S
    Zhonghua Nan Ke Xue; 2003; 9(4):273-4. PubMed ID: 12931369
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Interrelation of hyperactivity of bladder and infravesical obstruction in patients with benign prostate hyperplasia].
    Bablumyan A
    Georgian Med News; 2010 Dec; (189):7-11. PubMed ID: 21252402
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Role of blood supply disturbance and tissue hypoxia in the development of bladder dysfunction in bladder outlet obstruction caused by the prostatic adenoma].
    Kirpatovskiĭ VI; Sivkov AV; Fediakov RP; Khromov RA; Bablumian AIu; Nadtochiĭ ON
    Urologiia; 2013; (2):123-8. PubMed ID: 23789378
    [No Abstract]   [Full Text] [Related]  

  • 68. Effects of tadenan pretreatment on bladder physiology and biochemistry following partial outlet obstruction.
    Levin RM; Riffaud JP; Bellamy F; Rohrmann D; Krasnopolsky L; Haugaard N; Zhao Y; Wein AJ
    J Urol; 1996 Dec; 156(6):2084-8. PubMed ID: 8911395
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pressure-to-cross-sectional area relationships in the proximal urethra of men with bladder outlet obstruction.
    Graversen PH; Bagi P; Tofft HP; Colstrup H; Kristensen JK
    J Urol; 1996 Jan; 155(1):267-70. PubMed ID: 7490852
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Correlation between intravesical pressure and prostatic obstruction grade using computational fluid dynamics in benign prostatic hyperplasia.
    Lee MK; Lee SH; Hur N; Kim S; Kim S; Choi B
    Proc Inst Mech Eng H; 2011 Sep; 225(9):920-8. PubMed ID: 22070029
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Determination of infravesical obstruction in men with benign prostatic hyperplasia using pressure-flow measurement and analysis with the Dx/CLIM software program].
    Svihra J; Bos R; Rollema HJ; Janknegt RA
    Bratisl Lek Listy; 1997 Jan; 98(1):28-31. PubMed ID: 9264802
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Indoramin in the treatment of prostatic bladder outflow obstruction.
    Stott MA; Abrams P
    Br J Urol; 1991 May; 67(5):499-501. PubMed ID: 1710162
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Noninvasive methods to evaluate bladder obstruction in men.
    Elterman DS; Chughtai B; Lee R; Te AE; Kaplan SA
    Int Braz J Urol; 2013; 39(1):4-9. PubMed ID: 23489514
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of benign prostatic hyperplasia with phytosterols.
    Carbin BE; Larsson B; Lindahl O
    Br J Urol; 1990 Dec; 66(6):639-41. PubMed ID: 1702340
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Combined sabal and urtica extract vs. finasteride in benign prostatic hyperplasia (Alken stages I to II). Comment on the contribution by J. Sokeland and J. Albrech].
    Bartsch G; Dreikom K; Schöntöger PS
    Urologe A; 1998 Jan; 37(1):83-5. PubMed ID: 9540190
    [No Abstract]   [Full Text] [Related]  

  • 76. Urodynamics in benign prostatic hyperplasia (BPH).
    Schäfer W
    Arch Ital Urol Androl; 1993 Dec; 65(6):599-613. PubMed ID: 7508790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Urodynamic Features and Significant Predictors of Bladder Outlet Obstruction in Patients With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Small Prostate Volume.
    Kang M; Kim M; Choo MS; Paick JS; Oh SJ
    Urology; 2016 Mar; 89():96-102. PubMed ID: 26683755
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
    Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
    Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
    Jiang YH; Wang CC; Kuo HC
    PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Correlation of transrectal ultrasonographic findings of the prostate with the occurrence of detrusor instability in patients with benign prostatic hyperplasia.
    Tong YC; Lin YM; Yang WH; Tzai TS; Lin JS
    Urol Int; 1995; 55(3):154-7. PubMed ID: 8540161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.